A failed clinical trial HIV vaccine that left 46 Zambian women infected with the virus has sparked controversy.
The Microbicides Development Programme (MDP) 301 trial, which was testing if the gel PRO2000 would prevent HIV infection took place between September 2005 and 2009.
It was conducted at six research centres in South Africa, Tanzania, Uganda and Zambia and 9,385 participated.